Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus–ribonucleic acid in children and adolescents infected with human immunodeficiency virus

This publication has 19 references indexed in Scilit:

• Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter
  New England Journal of Medicine, 1995
• Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients
  AIDS, 1995
• Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
  The Journal of Infectious Diseases, 1995
• Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants
  The Journal of Pediatrics, 1995
• Human Immunodeficiency Virus Type 1 Quantitative Cell Microculture as a Measure of Antiviral Efficacy in a Multicenter Clinical Trial
  The Journal of Infectious Diseases, 1995
• Response of HIV RNA to didanosine as a predictive marker of survival
  AIDS, 1995
• Viral dynamics in human immunodeficiency virus type 1 infection
  Nature, 1995
• Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 Rna
  The Journal of Infectious Diseases, 1994
• Features of children perinatally infected with HIV-1 surviving longer than 5 years: Italian Register for HIV Infection in Children
  The Lancet, 1994
• Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection
  AIDS, 1994